Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BY 4.0Clinical Rheumatology

Single-cell eQTL Mendelian randomization reveals the monocyte-associated PRKCB–CTSL axis as a candidate regulatory pathway and potential therapeutic target in rheumatoid arthritis

4 affiliations
  1. 1Department of Pediatric Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Second Clinical Medical College of North Sichuan Medical College, No. 97 Renmin South Road, Shunqing, Nanchong, 637000 Sichuan China
  2. 2Department of Clinical Medicine, Ningxia Medical University, Hui Autonomous Region, Yinchuan, Ningxia 750004 People’s Republic of China
  3. 3School of Basic Medicine and Forensic Medicine, North Sichuan Medical College, No.234 Fujiang Road, Shunqing District, Nanchong, Sichuan, 637000 China
  4. 4North Sichuan Medical College, No. 234 Fu Jiang Road, Shunqing, Nanchong, 637000 Sichuan People’s Republic of China

Abstract

Objectives: Rheumatoid arthritis (RA) involves persistent immune dysregulation, but cell-specific genetically regulated pathways remain unclear. We integrated cell-specific genetic and multi-omics evidence to prioritize candidate regulatory pathways.

Methods: cis-eQTLs from 17 immune-cell populations were integrated with RA GWAS data by two-sample Mendelian randomization. Transcriptomics, WGCNA, and machine-learning feature selection identified convergent candidates. Single-cell and virtual perturbation analyses assessed cellular localization and downstream changes. Molecular docking and dynamics computationally prioritized compounds, and knockdown/rescue experiments evaluated the PRKCB–CTSL relationship.

Results: Eleven candidates had convergent genetic and transcriptomic support. PRKCB was retained by LASSO, SVM, and random forest and preferentially expressed in monocytes. Virtual perturbation implicated CTSL and antigen-processing/presentation pathways. PRKCB knockdown reduced CTSL expression and NF-κB phosphorylation, whereas CTSL restoration partially rescued NF-κB phosphorylation. Separately, structure-based analyses computationally prioritized ursodiol for the most favorable predicted PRKCB interaction among evaluated compounds.

Conclusions: Genetic, transcriptomic, single-cell, computational, and in vitro evidence supports monocyte-associated PRKCB–CTSL as a candidate regulatory pathway in RA. Further mechanistic and in vivo studies are required to establish its causal and pharmacological relevance. Key Points

• Multi-omics analysis identified 11 key RA-associated targets.

• RA was classified into two molecular subtypes with distinct immune features.

• PRKCB was identified as the core target enriched in monocytes.

• The PRKCB–CTSL axis may drive RA inflammation, and ursodiol showed therapeutic potential.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s10067-026-08482-4.

Related

  1. Bidirectional Mendelian randomization analysis reveals the causal relationship between rheumatoid arthritis and acute sinusitis
    Rui Hu, Yunwang Zhang, Yi Zeng +3
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Identification of genetically supported candidate therapeutic targets for angina pectoris using mendelian randomization
    Zixuan Wang, Dexin Wang, Longke Ran +2
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Rheumatoid Arthritis and Thrombocytopenia: Causal Evidence and Prognostic Implications From Observational and Mendelian Randomization Analyzes.
    Yejun Wu, Yuyang Cai, Anzhen Yang +4
    Immunity, inflammation and diseasePeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  4. Identification of Genes Associated with Gut Microbiota Metabolites in Type 2 Diabetes Mellitus Complicated by Acute Cerebral Infarction Based on Bioinformatics and Mendelian Randomization
    Guimei Zhang, Jiasheng Ju, Run Zhang +4
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Complement Component C4B Prioritization Through Drug‒Target Mendelian Randomization and Proteomic Analysis Reveals a Novel Therapeutic Target for Calcific Aortic Valve Stenosis
    Weijie Li, Ting Zhou, Songyuan Luo +8
    Cardiovascular Drugs and TherapyPeer-reviewedCC BY-NC-ND 4.0Full text1 citedCardiovascular medicinePMC
BibTeX
@article{wang2026singlecell,
  title = {{Single-cell eQTL Mendelian randomization reveals the monocyte-associated PRKCB–CTSL axis as a candidate regulatory pathway and potential therapeutic target in rheumatoid arthritis}},
  author = {Pengli Wang and Guohang Shen and Wenhua Liao and Ruoyan Wang and Li Zhang and Mingjia Zhao and Dong Zhang and Nanxiang Huang and Yupei Dai},
  journal = {Clinical Rheumatology},
  year = {2026},
  month = oct,
  doi = {10.1007/s10067-026-08482-4},
  url = {https://doi.org/10.1007/s10067-026-08482-4},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Single-cell eQTL Mendelian randomization reveals the monocyte-associated PRKCB–CTSL axis as a candidate regulatory pathway and potential therapeutic target in rheumatoid arthritis
AU  - Pengli Wang
AU  - Guohang Shen
AU  - Wenhua Liao
AU  - Ruoyan Wang
AU  - Li Zhang
AU  - Mingjia Zhao
AU  - Dong Zhang
AU  - Nanxiang Huang
AU  - Yupei Dai
PY  - 2026
DA  - 2026/10/19
JO  - Clinical Rheumatology
DO  - 10.1007/s10067-026-08482-4
UR  - https://doi.org/10.1007/s10067-026-08482-4
AB  - Objectives: Rheumatoid arthritis (RA) involves persistent immune dysregulation, but cell-specific genetically regulated pathways remain unclear. We integrated cell-specific genetic and multi-omics evidence to prioritize candidate regulatory pathways.  Methods: cis-eQTLs from 17 immune-cell populations were integrated with RA GWAS data by two-sample Mendelian randomization. Transcriptomics, WGCNA, and machine-learning feature selection identified convergent candidates. Single-cell and virtual perturbation analyses assessed cellular localization and downstream changes. Molecular docking and dynamics computationally prioritized compounds, and knockdown/rescue experiments evaluated the PRKCB–CTSL relationship.  Results: Eleven candidates had convergent genetic and transcriptomic support. PRKCB was retained by LASSO, SVM, and random forest and preferentially expressed in monocytes. Virtual perturbation implicated CTSL and antigen-processing/presentation pathways. PRKCB knockdown reduced CTSL expression and NF-κB phosphorylation, whereas CTSL restoration partially rescued NF-κB phosphorylation. Separately, structure-based analyses computationally prioritized ursodiol for the most favorable predicted PRKCB interaction among evaluated compounds.  Conclusions: Genetic, transcriptomic, single-cell, computational, and in vitro evidence supports monocyte-associated PRKCB–CTSL as a candidate regulatory pathway in RA. Further mechanistic and in vivo studies are required to establish its causal and pharmacological relevance. Key Points  • Multi-omics analysis identified 11 key RA-associated targets.  • RA was classified into two molecular subtypes with distinct immune features.  • PRKCB was identified as the core target enriched in monocytes.  • The PRKCB–CTSL axis may drive RA inflammation, and ursodiol showed therapeutic potential.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s10067-026-08482-4.
SN  - 0770-3198
SN  - 1434-9949
ER  -